Publikationen
Professor Dr. med. Christian P. Strassburg
Vogt A, Sievers E, Lukacs-Kornek V, Decker G, Raskopf E, Meumann N, Büning H, Sauerbruch T, Strassburg CP, Schmidt-Wolf IG, Gonzalez-Carmona MA.
Improvingimmunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC)engineered to express IL-12 in vivo.
Liver Int. 2013 Jul 30. doi:10.1111/liv.12284. [Epub ahead of print]
Lenzen H, Weismüller TJ, Negm AA, Wlecke J, Loges S, Strassburg CP, Manns MP, Lankisch TO.
Antineutrophil cytoplasmic antibodies in bile are associated withdisease activity in primary sclerosing cholangitis.
Scand J Gastroenterol. 2013 Oct;48(10):1205-12.
Schwarze-Zander C, Klingmüller D, Klümper J, Strassburg CP, Rockstroh JK.
Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal
suppression: description of a new case and review of the literature.
Infection.2013 Jul 20. [Epub ahead of print]
Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, Strassburg CP, Pröls M, Woźniak M, Manns MP; European Autoimmune Hepatitis-Budesonide Study Group.
Budesonide versus Prednisone with Azathioprine for the Treatment ofAutoimmune Hepatitis in Children and Adolescents.
J Pediatr. 2013 Jun 27. doi:pii: S0022-3476(13)00658-6. 10.1016/j.jpeds.2013.05.042. [Epub ahead of print]
Strassburg CP.
Autoimmune hepatitis.
Dig Dis. 2013;31(1):155-63.
Kalthoff S, Winkler A, Freiberg N, Manns MP, Strassburg CP.
Gender matters: Estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
J Hepatol. 2013 Oct;59(4):797-804.
Voigtländer T, Negm AA, Strassburg CP, Lehner F, Manns MP, Lankisch TO.
Biliary cast syndrome post-liver transplantation: risk factors and outcome.
Liver Int. 2013 Sep;33(8):1287-92.
Strassburg CP.
[Patient selection and indications for liver transplantation].
Chirurg. 2013 May;84(5):363-71.
Lutz P, Parcina M, Bekeredjian-Ding I, Hoerauf A, Strassburg CP, Spengler U.
Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with
rifaximin.
Infection. 2013 Mar 25. [Epub ahead of print]
Voigtländer T, Alten T, Lehner F, Strassburg CP, Manns MP, Lankisch TO.
[Secondary sclerosing cholangitis following liver transplantation: a rare cause for graft failure].
Z Gastroenterol. 2013 Mar;51(3):296-8.
Weismüller TJ, Bleich F, Negm AA, Schneider A, Lankisch TO, Manns MP, Strassburg CP, Wedemeyer J.
Screening colonoscopy in liver transplant candidates: risks and findings.
Clin Transplant. 2013 Mar-Apr;27(2):E161-8.
Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, Rümke S, Barg-Hock H, Strassburg CP, Hecker H, Tryc AB.
Comparison of the most favouredmethods for the diagnosis of hepatic encephalopathy in liver transplantation candidates.
Gut. 2013 Oct;62(10):1497-504.
Blume C, Sensoy A, Gross MM, Guenter HH, Haller H, Manns MP, Schwarz A, Lehner F, Klempnauer J, Pischke S, Strassburg CP.
A comparison of the outcome of pregnancies after liver and kidney transplantation. Transplantation. 2013 Jan 15;95(1):222-7.
Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, Pflugrad H, Barg-Hock H, Strassburg CP, Hecker H, Weissenborn K.
Cirrhosis-relatedParkinsonism: prevalence, mechanisms and response to treatments. J Hepatol. 2013 Apr;58(4):698-705.
Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO.
Secondary sclerosing cholangitis in critically ill patients: modelof end-stage liver disease score and renal function predict outcome.
Endoscopy.2012 Nov;44(11):1055-8.
Strassburg CP.
Autoimmune hepatitis: new guidelines, new therapies.
Dig Dis. 2012;30 Suppl 1:11-9.
Hadem J, Strassburg CP, Manns MP.
Prediction of outcome and selection of the liver transplantat candidate in acute liver failure.
Front Physiol. 2012;3:340.
Rifai K, Hadem J, Wiegand J, Potthoff A, Pischke S, Klempnauer J, Strassburg C, Wedemeyer H, Manns MP, Tillmann HL.
Gender differences in patient receivingliver transplantation for viralhepatitis.
Z Gastroenterol. 2012 Aug;50(8):760-5.
Clajus C, Hanke N, Gottlieb J, Stadler M, Weismüller TJ, Strassburg CP, Bröcker V, Bara C, Lehner F, Drube J, Kielstein JT, Schwarz A, Gueler F, Haller H, Schiffer M.
Renal Comorbidity After Solid Organ and Stem Cell Transplantation.
Am J Transplant. 2012 Jul;12(7):1691-1699.
von Hahn T, Schiene-Fischer C, Van ND, Pfänder S, Karavul B, Steinmann E, Potthoff A, Strassburg C, Hamdi N, Abdelaziz AI, Sarrazin C, Müller T, Berg T, Trépo E, Wedemeyer H, Manns MP, Pietschmann T, Ciesek S.
Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication.
Gastroenterology. 2012 May 8. [Epub ahead of print]
Pischke S, Gösling J, Engelmann I, Schlue J, Wölk B, Jäckel E, Meyer-Heithuis C, LehmannU, Strassburg CP, Barg-Hock H, Becker T, Manns MP, Schulz T, Wedemeyer H, Heim A. High intrahepatic HHV-6 virus loads but neither CMV nor EBV areassociated with decreased graft survival after diagnosis of graft hepatitis.
JHepatol. 2012 May;56(5):1063-9.
Ehmer U, Kalthoff S, Fakundiny B, Pabst B, Freiberg N, Naumann R, Manns MP, Strassburg CP.
Gilbert syndrome redefined: a complex genetic haplotype influencesthe regulation of glucuronidation.
Hepatology. 2012 Jun;55(6):1912-21.
Mederacke I, Helfritz F, Puls F, Ringe KI, Klempnauer J, Manns MP, Strassburg CP.
Budd-Chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis.
Ann Hepatol. 2012 Jan-Feb;11(1):143-4.
Strassburg CP.
[The ABC of hepatitis].
MMW Fortschr Med. 2011 Jan20;153(3):36-40; quiz 41.
Schrem H, Reichert M, Reichert B, Becker T, Lehner F, Kleine M, Bektas H,Johanning K, Strassburg CP, Klempnauer J.
Value of the SOFA score as a predictivemodel for short-term survival in high-risk liver transplant recipients with apre-transplant labMELD score ≥ 30.
Langenbecks Arch Surg. 2012 Jun;397(5):717-26.
Strassburg CP, Manns MP.
Therapy of autoimmune hepatitis.
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):673-87.
Strassburg CP, Manns MP, Wedemeyer J.
Recurrent acute pancreatitis in a young woman with a history of asymptomatic lipase elevations for several years.
Gastroenterology. 2012 Jan;142(1):e8-9.
Strassburg CP, Manns MP.
[Treatment of autoimmune liver diseases. Autoimmune
hepatitis and primary sclerosing cholangitis].
Internist (Berl). 2011Dec;52(12):1394-406.
May M, Gueler F, Barg-Hock H, Heiringhoff KH, Engeli S, Heusser K, DiedrichA, Brandt A, Strassburg CP, Tank J, Sweep FC, Jordan J.
Liver afferentscontribute to water drinking-induced sympathetic activation in human subjects: a clinical trial.
PLoS One. 2011;6(10):e25898.
Weismüller TJ, Kirchner GI, Scherer MN, Negm AA, Schnitzbauer AA, Lehner F,Klempnauer J, Schlitt HJ, Manns MP, Strassburg CP.
Serum ferritin concentrationand transferrin saturation before liver transplantation predict decreased long-term recipient survival.
Hepatology. 2011 Dec;54(6):2114-24.
Manns MP, Strassburg CP.
Therapeutic strategies for autoimmune hepatitis.
DigDis. 2011;29(4):411-5.
Mederacke I, Filmann N, Yurdaydin C, Bremer B, Puls F, Zacher BJ, Heidrich B,Tillmann HL, Rosenau J, Bock CT, Savas B, Helfritz F, Lehner F, Strassburg CP,Klempnauer J, Wursthorn K, Lehmann U, Manns MP, Herrmann E, Wedemeyer H.
Rapidearly HDV RNA decline in the peripheral blood but prolonged intrahepatic
hepatitis delta antigen persistence after liver transplantation.
J Hepatol. 2012 Jan;56(1):115-22.
Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, Hamdi N,Abdelaziz AI, Strassburg CP, Wedemeyer H, Manns MP, Pietschmann T, von Hahn T.
Impact of intra- and interspecies variation of occludin on its function ascoreceptor for authentic hepatitis C virus particles.
J Virol. 2011Aug;85(15):7613-21.
Vogel A, Ockenga J, Tukey RH, Manns MP, Strassburg CP.
Genotyping of theUDP-glucuronosyltransferase (UGT) 1A7 gene revisited.
Gastroenterology. 2011May;140(5):1692-3.
Pischke S, Karsten W, Hadem J, Schmidt S, Heiringhoff Heinz K, Helfritz F,Strassburg CP, Lobers J, Zender L, Tutarel O, Wedemeyer J, Manns MP, Wedemeyer H, Rifai K, Gebel M.
Liver transplantation: A new risk factor for intestinal intussusceptions.
Ann Hepatol. 2011 Jan-Mar;10(1):38-42.
Schlitt HJ, Loss M, Scherer MN, Becker T, Jauch KW, Nashan B, Schmidt H,Settmacher U, Rogiers X, Neuhaus P, Strassburg C.
[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].
Z Gastroenterol. 2011 Jan;49(1):30-8.
Strassburg CP.
Autoimmune hepatitis.
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):667-82.
Strassburg CP.
Hyperbilirubinemia syndromes (Gilbert-Meulengracht,Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).
Best Pract Res ClinGastroenterol. 2010 Oct;24(5):555-71.
Schwarz A, Haller H, Schmitt R, Schiffer M, Koenecke C, Strassburg C, Lehner F, Gottlieb J, Bara C, Becker JU, Broecker V.
Biopsy-diagnosed renal disease inpatients after transplantation of other organs and tissues.
Am J Transplant. 2010Sep;10(9):2017-25.
Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, Neuhaus P, Klempnauer J, Pratschke J, Manns MP, Strassburg CP.
Multicentric evaluation of model for end-stage liverdisease-based allocation and survival after liver transplantation inGermany--limitations of the 'sickest first'-concept.
Transpl Int. 2011Jan;24(1):91-9.
Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, Bahr MJ,Günther R, Hultcrantz RW, Spengler U, Lohse AW, Szalay F, Färkkilä M, Pröls M,Strassburg CP; European AIH-BUC-Study Group.
Budesonide induces remission moreeffectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
Gastroenterology. 2010 Oct;139(4):1198-206.
Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP.
Coffee inducesexpression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach.
Gastroenterology. 2010 Nov;139(5):1699-710, 1710.e1-2.
Strassburg CP.
Transplantationshepatologie: aktuelle Herausforderungen
Arzneimittelforschung 2010;60(11):723–26
Weismüller TJ, Manns MP, Strassburg CP.
Ferritin and liver allocation? Impacton mortality not only on the waiting list but also after orthotopic livertransplantation should be considered.
Hepatology. 2010 Jul;52(1):392-3; authorreply 393.
Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S,Strassburg CP, Manns MP, Suerbaum S, Wedemeyer J, Lankisch TO.
Routine bilecollection for microbiological analysis during cholangiography and its impact on the management of cholangitis.
Gastrointest Endosc. 2010 Aug;72(2):284-91.
Ciesek S, Becker T, Manns MP, Strassburg CP.
Anti-parietal cellautoantibodies (PCA) in primary biliary cirrhosis: a putative marker forrecurrence after orthotopic liver transplantation?
Ann Hepatol. 2010Apr-Jun;9(2):181-5.
Strassburg CP.
Therapeutic options to treat autoimmune hepatitis in 2009.
DigDis. 2010;28(1):93-8.
Ehmer U, Kalthoff S, Lankisch TO, Freiberg N, Manns MP, Strassburg CP.
Sharedregulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha.
Drug Metab Dispos. 2010 Jul;38(7):1246-57.
Erichsen TJ, Aehlen A, Ehmer U, Kalthoff S, Manns MP, Strassburg CP.
Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the
farnesoid X receptor and bile acids.
J Hepatol. 2010 Apr;52(4):570-8.
Pischke S, Tutarel O, Greten TF, Heim A, Wedemeyer J, Herzog P, Saddekni N,Barg-Hock H, Strassburg C, Manns MP, Rifai K, Gebel M.
[CMV-enterocolitis as acause for repeated intestinal intussusceptions in an adult patient after liver transplantation?].
Z Gastroenterol. 2010 Jun;48(6):688-92.
Stange MA, Tutarel O, Pischke S, Schneider A, Strassburg CP, Becker T,Barg-Hock H, Bastürk M, Wursthorn K, Cornberg M, Ott M, Greten TF, Manns MP, Wedemeyer H.
Fulminant hepatic failure due to chemotherapy-induced hepatitis Breactivation: role of rituximab.
Z Gastroenterol. 2010 Feb;48(2):258-63.
Halank M, Strassburg CP, Hoeper MM.
[Pulmonary complications of livercirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax].
Internist (Berl). 2010 Mar;51 Suppl 1:255-63.
Pischke S, Ehmer U, Schedel I, Gratz WF, Wedemeyer H, Ziesing S, Bange FC,Burchard GD, Manns MP, Bahr MJ, Strassburg CP.
Of guinea pigs and men--an unusual case of jaundice.
Z Gastroenterol. 2010 Jan;48(1):33-7.
Strassburg CP.
Gilbert-Meulengracht's syndrome and pharmacogenetics: isjaundice just the tip of the iceberg?
Drug Metab Rev. 2010 Feb;42(1):168-81.
Tutarel O, Barg-Hock H, Pischke S, Bahr MJ, Kreipe HH, Greten TF, Manns MP, Strassburg CP.
Mycosis fungoides with involvement of the larynx after liver transplantation in an adult.
Am J Gastroenterol. 2010 Jan;105(1):238-40.
Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP.
Interaction betweenoxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptorin the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.
J Biol Chem. 2010 Feb 26;285(9):5993-6002.
Strassburg CP, Cornberg M.
[Diagnostics and therapy of hepatitis].
Internist (Berl). 2009 Dec;50(12):1358-68.
Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S,Manns MP, Strassburg CP, Wedemeyer J.
Clinical relevance of transjugular liverbiopsy in comparison with percutaneous and laparoscopic liver biopsy.
Gastroenterol Res Pract. 2009;2009:947014.
Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H.
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
Liver Transpl. 2010 Jan;16(1):74-82.
Deterding K, Grüngreiff K, Lankisch TO, Potthoff A, Bahr MJ, Manns MP, Wedemeyer H, Strassburg CP.
Gilbert's syndrome and antiviral therapy of hepatitis C.
Ann Hepatol. 2009 Jul-Sep;8(3):246-50.
Volkmann M, Luithle D, Zentgraf H, Schnölzer M, Fiedler S, Heid H,Schulze-Bergkamen A, Strassburg CP, Gehrke SG, Manns MP.
SLA/LP/tRNP((Ser)Sec)antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
J Autoimmun. 2010 Feb;34(1):59-65.
Lankisch TO, Jaeckel E, Strassburg CP.
The autoimmunepolyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Semin Liver Dis. 2009 Aug;29(3):307-14.
Strassburg CP, Manns MP.
Treatment of autoimmune hepatitis.
Semin Liver Dis. 2009 Aug;29(3):273-85.
Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
The introduction of MELD-based organ allocation impacts 3-monthsurvival after liver transplantation by influencing pretransplant patient characteristics.
Transpl Int. 2009 Oct;22(10):970-8.
Potthoff A, Rifai K, Wedemeyer H, Deterding K, Manns M, Strassburg C.
Successful treatment of fulminant hepatitis B during pregnancy.
Z Gastroenterol. 2009 Jul;47(7):667-70.
Schrem H, Barg-Hock H, Strassburg CP, Schwarz A, Klempnauer J.
Aftercare for patients with transplanted organs.
Dtsch Arztebl Int. 2009 Feb;106(9):148-56.
Takebe A, Schrem H, Ringe B, Lehner F, Strassburg C, Klempnauer J, Becker T.
Extended right liver grafts obtained by an ex situ split can be used safely forprimary and secondary transplantation with acceptable biliary morbidity.
LiverTranspl. 2009 Jul;15(7):730-7.
Strassburg CP, Manns MP.
[Liver transplantation: indications and results].
Internist (Berl). 2009 May;50(5):550-60.
Strassburg CP, Manns MP.
[Transplantation medicine 2009].
Internist (Berl).2009 May;50(5):521-2.
Höblinger A, Erdmann C, Strassburg CP, Sauerbruch T, Lammert F.
Coinheritanceof hereditary spherocytosis and reversibility of cirrhosis in a young femalepatient with hereditary hemochromatosis.
Eur J Med Res. 2009 Apr 16;14(4):182-4.
Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, Dietze O, Hutter J, Manns MP, Datz C.
Transient autoimmune hepatitis induced by a thymoma.
Am JGastroenterol. 2009 May;104(5):1332-4.
Lankisch TO, Mourier O, Sokal EM, Habes D, Lacaille F, Bridoux-Henno L,Hermeziu B, Lenaerts C, Strassburg CP, Jacquemin E.
AIRE gene analysis inchildren with autoimmune hepatitis type I or II.
J Pediatr Gastroenterol Nutr.2009 Apr;48(4):498-500.
Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP.
Gilbert's syndrome andhyperbilirubinemia in protease inhibitor therapy--an extended haplotype ofgenetic variants increases risk in indinavir treatment.
J Hepatol. 2009May;50(5):1010-8.
Strassburg CP, Lehner F, Kreipe HH.
Clinical challenges and images in GI.Image 3: Madelung syndrome.
Gastroenterology. 2009 Feb;136(2):406, 732.
Strassburg CP, Kalthoff S, Ehmer U.
Variability and function of family 1uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
Crit Rev Clin Lab Sci.2008;45(6):485-530.
Ehmer U, Lankisch TO, Erichsen TJ, Kalthoff S, Freiberg N, Wehmeier M, Manns MP, Strassburg CP.
Rapid allelic discrimination by TaqMan PCR for the detectionof the Gilbert's syndrome marker UGT1A1*28.
J Mol Diagn. 2008 Nov;10(6):549-52.
Kousoulas L, Neipp M, Barg-Hock H, Jackobs S, Strassburg CP, Klempnauer J, Becker T.
Health-related quality of life in adult transplant recipients more than15 years after orthotopic liver transplantation.
Transpl Int. 2008Nov;21(11):1052-8.
Lankisch TO, Gillman TC, Erichsen TJ, Ehmer U, Kalthoff S, Freiberg N, Munzel PA, Manns MP, Strassburg CP.
Aryl hydrocarbon receptor-mediated regulation of the
human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.
Arch Toxicol. 2008 Sep;82(9):573-82.
Suneetha PV, Mederacke I, Heim A, Bastürk M, Cornberg M, Strassburg CP, Manns MP, Wedemeyer H.
Spontaneous clearance of chronic hepatitis C after livertransplantation: are hepatitis C virus-specific T cell responses the clue?
Liver Transpl. 2008 Aug;14(8):1225-7.
Weismüller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
Prediction of survival after liver transplantation by pre-transplant parameters.
Scand J Gastroenterol. 2008;43(6):736-46.
Strassburg CP.
Pharmacogenetics of Gilbert's syndrome.
Pharmacogenomics. 2008Jun;9(6):703-15.
Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP.
Recurrence of primary sclerosing cholangitis after livertransplantation – A model for pathogenesis?
J Hepatol. 2008; 49(5): 864-65.
Strassburg CP, Lankisch TO, Manns MP, Ehmer U.
Family 1uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
Arch Toxicol. 2008 Jul;82(7):415-33.
Erichsen TJ, Ehmer U, Kalthoff S, Lankisch TO, Müller TM, Munzel PA, Manns MP, Strassburg CP.
Genetic variability of aryl hydrocarbon receptor(AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.
Toxicol Appl Pharmacol. 2008 Jul 15;230(2):252-60.
Lankisch TO, Schulz C, Zwingers T, Erichsen TJ, Manns MP, Heinemann V, Strassburg CP.
Gilbert's Syndrome and irinotecan toxicity: combination withUDP-glucuronosyltransferase 1A7 variants increases risk.
Cancer EpidemiolBiomarkers Prev. 2008 Mar;17(3):695-701.
Grannas G, Neipp M, Hoeper MM, Gottlieb J, Lück R, Becker T, Simon A,Strassburg CP, Manns MP, Welte T, Haverich A, Klempnauer J, Nashan B, Strueber M.
Indications for and outcomes after combined lung and liver transplantation: asingle-center experience on 13 consecutive cases.
Transplantation. 2008 Feb27;85(4):524-31.
Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP.
Thechallenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
J Hepatol. 2008;48 Suppl 1:S38-57.
Ciesek S, Helfritz FA, Lehmann U, Becker T, Strassburg CP, Neipp M, Ciner A, Fytili P, Tillmann HL, Manns MP, Wedemeyer H.
Persistence of occult hepatitis Bafter removal of the hepatitis B virus-infected liver.
J Infect Dis. 2008 Feb1;197(3):355-60.
Strassburg CP, Bahr MJ, Becker T, Klempnauer J, Manns MP.
[Progress in immunosuppression].
Chirurg. 2008 Feb;79(2):149-56.
Schrem H, Till N, Becker T, Bektas H, Manns MP, Strassburg CP, Klempnauer J.
[Long-term results after liver transplantation].
Chirurg. 2008 Feb;79(2):121-9.
Boozari B, Nashan B, Hecker H, Kubicka S, Klempnauer J, Strassburg C, Manns M, Gebel MJ.
The type of arterial anastomosis influences hepatic hemodynamics andoverall survival in liver graft recipients.
Ultraschall Med. 2007Dec;28(6):587-92.
Rifai K, Wedemeyer H, Rosenau J, Klempnauer J, Strassburg CP, Manns MP, Tillmann HL.
Longer survival of liver transplant recipients with hepatitis virus coinfections.
Clin Transplant. 2007 Mar-Apr;21(2):258-64.
Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL,Klempnauer J, Strassburg CP, Manns MP.
Failure of hepatitis B vaccination withconventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
Liver Transpl. 2007 Mar;13(3):367-73.
Potthoff A, Deterding K, Trautwein C, Flemming P, Strassburg CP, Manns MP, Wedemeyer H, Bahr MJ.
Steroid treatment for severe acute cryptogenic hepatitis.
ZGastroenterol. 2007 Jan;45(1):15-9.
Strassburg CP.
What is the influence of genotype on the success of treatment for chronic hepatitis B? Nat Clin Pract Gastroenterol Hepatol. 2006Nov;3(11):620-1.
Schneider A, Attaran M, Meier PN, Strassburg C, Manns MP, Ott M, Barthold M, Arseniev L, Becker T, Panning B.
Hepatocyte transplantation in an acute liver
failure due to mushroom poisoning.
Transplantation. 2006 Oct 27;82(8):1115-6.
Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP.
Gilbert's disease and atazanavir: from phenotype toUDP-glucuronosyltransferase haplotype.
Hepatology. 2006 Nov;44(5):1324-32.
Strassburg CP, Manns MP.
Approaches to liver biopsy techniques--revisited.
Semin Liver Dis. 2006 Nov;26(4):318-27.
Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M.
Characterization and clinical course of hepatobiliary carcinoma inpatients with primary sclerosing cholangitis.
Scand J Gastroenterol. 2006Oct;41(10):1227-34.
Strassburg CP.
[Autoimmune liver diseases and their overlap syndromes].
Praxis (Bern 1994). 2006 Sep 6;95(36):1363-81.
Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, Nashan B,Klempnauer J, Strassburg CP, Wedemeyer H, Manns MP.
Hepatitis B virusimmunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
Transpl Int. 2006 Oct;19(10):828-33.
Strassburg CP, Manns MP.
Autoimmune hepatitis in the elderly: what is the difference?
J Hepatol. 2006 Oct;45(4):480-2.
Ciesek S, Hadem J, Fischer J, Manns MP, Strassburg CP.
A rare cause ofnonalcoholic fatty liver disease.
Ann Intern Med. 2006 Jul 18;145(2):154-5.
Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C,Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns MP.
Outcome and quality oflife in patients with polycystic liver disease after liver or combinedliver-kidney transplantation.
Liver Transpl. 2006 Aug;12(8):1268-77.
Ciesek S, Manns M, Strassburg C.
[Sequelae of organ transplantation].
Internist (Berl). 2006 Mar;47(3):252, 254-6, 258-60 passim.
Rifai K, Kirchner GI, Bahr MJ, Cantz T, Rosenau J, Nashan B, Klempnauer JL, Manns MP, Strassburg CP.
A new side effect of immunosuppression: high incidenceof hearing impairment after liver transplantation.
Liver Transpl. 2006Mar;12(3):411-5.
Strassburg CP.
[Diagnosis and therapy: autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis].
Dtsch Med Wochenschr. 2005 Dec16;130 Suppl 5:S202-4.
Boozari B, Gebel M, Bahr MJ, Manns MP, Strassburg CP, Bleck JS, Klempnauer J, Nashan B.
Changes of duplex parameters and splenic size in liver transplantrecipients during a long period of observation.
World J Gastroenterol. 2005 Nov21;11(43):6787-91.
Ellis E, Wagner M, Lammert F, Nemeth A, Gumhold J, Strassburg CP, Kylander C,Katsika D, Trauner M, Einarsson C, Marschall HU.
Successful treatment of severeunconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin.
J Hepatol.2006 Jan;44(1):243-5.
Wedemeyer J, Gratz KF, Soudah B, Rosenthal H, Strassburg C, Terkamp C, BahrMJ, Manns MP, Gebel MJ, Bleck JS.
[Splenosis--important differential diagnosis insplenectomized patients presenting with abdominal masses of unknown origin].